| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.07 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.08 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.08 |